Mometasone Furoate Nasal Spray is indicated for the treatment of seasonal or perennial rhinitis in adults, adolescents, and children aged 3 to 11 years. For patients who have had moderate to severe seasonal allergic rhinitis, it is recommended that this product be used as a prophylactic treatment 2-4 weeks before the start of the pollen season.
Mometasone Furoate Nasal Spray belongs to the glucocorticoid class of drugs, has a strong anti-inflammatory, anti-allergic effect, belongs to the local use of drugs, basically does not produce systemic side effects, mainly on the surface of the nasal mucous membrane, can reduce the nasal secretion, thus effectively reducing sneezing, nasal itching, nasal congestion, runny nose and other rhinitis symptoms.
A few people may experience adverse reactions after use, such as nosebleed, pharyngitis, burning sensation of the nose, nasal irritation and so on.
Mometasone Furoate Nasal Spray is a prescription drug and the drug should be used under the supervision of a physician.